chromophore and of homologues in the cyclic amidine ring
using phenolic oxidation by hypervalent iodine.11
The required substrates for oxidation were the phenolic
cyclic amidines 7-9. These were all prepared from 2-(4-
hydroxyphenyl)propanoic acid 10 by the sequence outlined
in Scheme 1. Treatment with benzyl bromide (K2CO3,
Figure 2. Tetrahydropyrimidine pseudodipeptides.
other related metabolites such as ferribactins,6 which lack
the chromophore but contain the tyrosine-based tetrahydro-
pyrimidine 3, isopyoverdins 4,7 and the corresponding 5,6-
dihydro metabolites 5 and 6 (Figure 3).8
Scheme 1. Synthesis of Cyclic Amidine Oxidation Substrates
acetone reflux) and subsequent ester hydrolysis (NaOH,
MeOH aq) afforded the benzyl ether (98%) which was
converted into amide 11 via the acid chloride (oxalyl
chloride, THF, DMF cat.; 96%) and ammonolysis (NH3 aq,
d 0.88, THF; 76%). After less reliable attempts at O-
alkylation with Meerwein’s salt, our preferred protocol for
carboxamide activation was treatment with methyl trifluo-
romethanesulfonate (CH2Cl2, reflux) to afford the imidate
salt 12 (we have also successfully employed S-alkylation of
piperidine thioamides to achieve this carboxyl activation4).
The crude imidate was treated directly with the appropriate
diamine (EtOH, reflux) to form the required cyclic amidine.
Thus, 1,3-diaminopropane led to the tetrahydropyrimidine
13 (n ) 1) (83%)12 as its trifluoromethanesulfonate salt
which was debenzylated by hydrogenolysis (Pd-C, 1 atm
H2, EtOH) to afford oxidation substrate 7 (99%). Likewise,
reaction of 12 with 1,2-diaminoethane or 1,4-diaminobutane,
and subsequent hydrogenolysis, led to the corresponding
imidazoline 8 (75 and 99%)12 and 1,3-diazepine 9 (24 and
97%), respectively, again as the trifluoromethanesulfonate
salts.
Figure 3. Cometabolites biogenetically related to pyoverdins.
The recent demonstration of enzymic oxidation of the
simple analogue 7 of tetrahydropyrimidine 3 to form a model
for the dihydropyrimido[1,2-a]quinoline chromophore, albeit
in very low yield,9,10 prompts us to report here our biomi-
metic chemical synthesis of a model for the pyoverdin
(5) (a) Thompson, B. N.; Gould, S. J. Tetrahedron 1994, 50, 9865–
9872. (b) Bo¨ckmann, M.; Taraz, K.; Budziekewicz, K. Z. Naturforsch. C:
Biosci. 1997, 52, 319–324.
(6) Hohlneicher, U.; Hartmann, R.; Taraz, K.; Budziekewicz, H. Z.
Naturforsch. 1995, 50C, 337–344.
(7) Jacques, Ph.; Ongena, M.; Gwose, I.; Seinsche, D.; Schro¨der, H.;
Delfosse, Ph.; Thonart, Ph.; Taraz, K.; Budziekewicz, H. Z. Naturforsch.
1995, 50C, 622–629.
(8) (a) Gwose, I.; Taraz, K. Z. Naturforsch. 1992, 47C, 487–502. (b)
Michalke, R.; Taraz, K.; Budziekewicz, H.; Thonart, Ph.; Jacques, Ph. Z.
Naturforsch. 1995, 50C, 855–857.
(9) Dorrestein, P. C.; Poole, K.; Begley, T. P. Org. Lett. 2003, 5, 2215–
2217
.
Oxidative cyclization of tetrahydropyrimidine 7 to the
pyoverdin chromophore ring system requires closure via a
nitrogen atom. Our own studies and the work of others have
clearly demonstrated that primary amides such as 11 or the
corresponding piperidine amides cyclize via the carbonyl
oxygen atom on iodine(III) oxidation.13 Ring closure via
nitrogen has been demonstrated for acyl hydrazides,14
sulfonamides,15 or cyclic imidates (oxazines, dihydroox-
(10) (a) Routes to cyclic amidine [1,2-a]-fused quinolines have also been
reported by closure of the amidine ring as the final step using conventional
or electrochemical protocols. See, for example: Jones, R. C. F.; Smallridge,
M. J.; Chapleo, C. B. J. Chem. Soc., Perkin Trans. 1 1990, 38, 5–391. (b)
Okimoto, M.; Yoshida, T.; Hoshi, M.; Hattori, K.; Komata, M.; Numata,
K.; Tomozawa, K. Aust. J. Chem. 2007, 60, 236–242
.
(11) (a) Wirth, T. Angew. Chem., Int. Ed. 2005, 44, 3656–3665. (b)
Wirth, T. HyperValent Iodine Chemistry: Modern DeVelopments in Organic
Synthesis; Wirth, T., Ed.; Springer: Berlin, 2003; Vol. 224, pp 185-208.
(c) Tohma, H.; Kita, Y. HyperValent Iodine Chemistry: Modern DeVelop-
ments in Organic Synthesis; Wirth, T., Ed.; Springer: Berlin, 2003; Vol.
224, pp 209-248.
(12) Some recovered amide 11 was isolated along with tetrahydro-
pyrimidine 13 (n ) 1) and imidazoline 13 (n ) 0) (15 and 4%,
respectively).
(13) (a) Smith, J. E. M.Phil. Thesis, The Open University, 2004. (b)
Kita, Y.; Tohma, H.; Kikuchi, K.; Inagaki, M.; Yakura, T. J. Org. Chem.
1991, 56, 435–438.
1520
Org. Lett., Vol. 11, No. 7, 2009